Robert Press

1.0k total citations
19 papers, 797 citations indexed

About

Robert Press is a scholar working on Infectious Diseases, Surgery and Epidemiology. According to data from OpenAlex, Robert Press has authored 19 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 8 papers in Surgery and 4 papers in Epidemiology. Recurrent topics in Robert Press's work include Antimicrobial Resistance in Staphylococcus (5 papers), Surgical site infection prevention (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Robert Press is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (5 papers), Surgical site infection prevention (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Robert Press collaborates with scholars based in United States and Vietnam. Robert Press's co-authors include Frank C. Spencer, Karl H. Krieger, Eugene A. Grossi, David Kloth, F.Gregory Baumann, Alfred T. Culliford, Kenneth Inglima, Satish K. Pillai, Lata Venkataraman and Howard S. Gold and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Clinical Infectious Diseases and Brain Research.

In The Last Decade

Robert Press

19 papers receiving 745 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Press United States	13	353	267	193	125	106	19	797
Geoffrey K. Richards Canada	15	180 0.5×	137 0.5×	155 0.8×	80 0.6×	42 0.4×	49	581
Dori F. Zaleznik United States	13	408 1.2×	160 0.6×	238 1.2×	35 0.3×	107 1.0×	21	935
Florian Hitzenbichler Germany	18	167 0.5×	412 1.5×	212 1.1×	62 0.5×	63 0.6×	63	833
Christian Eckmann Germany	11	190 0.5×	119 0.4×	242 1.3×	106 0.8×	82 0.8×	23	925
John L. Brusch United States	12	106 0.3×	219 0.8×	299 1.5×	64 0.5×	83 0.8×	23	659
A. Dine United States	6	316 0.9×	728 2.7×	572 3.0×	91 0.7×	58 0.5×	6	1.2k
Janne Kataja Finland	16	103 0.3×	319 1.2×	382 2.0×	90 0.7×	73 0.7×	37	918
T. Pruett United States	13	313 0.9×	71 0.3×	114 0.6×	75 0.6×	29 0.3×	72	675
W. John Spicer Australia	13	92 0.3×	145 0.5×	107 0.6×	69 0.6×	63 0.6×	34	469
Wolfgang A. Krueger Germany	21	134 0.4×	317 1.2×	552 2.9×	171 1.4×	77 0.7×	44	1.5k

Countries citing papers authored by Robert Press

Since Specialization

Citations

This map shows the geographic impact of Robert Press's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Press with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Press more than expected).

Fields of papers citing papers by Robert Press

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Press. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Press. The network helps show where Robert Press may publish in the future.

Co-authorship network of co-authors of Robert Press

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Press. A scholar is included among the top collaborators of Robert Press based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Press. Robert Press is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Mohan, Sanjay, et al.. (2020). Use of a telehealth follow-up system to facilitate treatment and discharge of emergency department patients with severe cellulitis. The American Journal of Emergency Medicine. 41. 184–189. 11 indexed citations

Dubrovskaya, Yanina, et al.. (2019). Dalbavancin Use in the Emergency Department Setting. Annals of Pharmacotherapy. 53(11). 1093–1101. 14 indexed citations

Volpicelli, Frank, Nicole Adler, Simon Jones, et al.. (2019). Bending the cost curve: time series analysis of a value transformation programme at an academic medical centre. BMJ Quality & Safety. 28(6). 449–458. 12 indexed citations

Dubrovskaya, Yanina, et al.. (2014). Fidaxomicin Therapy in Critically Ill Patients with Clostridium difficile Infection. Antimicrobial Agents and Chemotherapy. 59(3). 1776–1781. 28 indexed citations

Phillips, Michael, Andrew Rosenberg, Bo Shopsin, et al.. (2014). Preventing Surgical Site Infections: A Randomized, Open-Label Trial of Nasal Mupirocin Ointment and Nasal Povidone-Iodine Solution. Infection Control and Hospital Epidemiology. 35(7). 826–832. 99 indexed citations

Clutter, Dana, et al.. (2013). Fidaxomicin versus Conventional Antimicrobial Therapy in 59 Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation with Clostridium difficile-Associated Diarrhea. Antimicrobial Agents and Chemotherapy. 57(9). 4501–4505. 43 indexed citations

Hansen, Luke O., Lois E. H. Smith, Jungwha Lee, et al.. (2011). Hospital discharge documentation and risk of rehospitalisation. BMJ Quality & Safety. 20(9). 773–778. 43 indexed citations

David, Richard, Peter M.C. DeBlieux, & Robert Press. (2005). Rational antibiotic treatment of outpatient genitourinary infections in a changing environment. The American Journal of Medicine. 118(7). 7–13. 21 indexed citations

Pillai, Satish K., et al.. (2003). Linezolid-Resistant, Vancomycin-Resistant Enterococcus faecium Infection in Patients without Prior Exposure to Linezolid. Clinical Infectious Diseases. 36(11). e146–e148. 104 indexed citations

10.

Press, Robert. (2001). The Use of Fluoroquinolones as Antiinfective Transition‐Therapy Agents in Community‐Acquired Pneumonia. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(7P2). 100S–104S. 5 indexed citations

11.

Jacobs, Joseph B., et al.. (1992). Recurrent Mucormycosis of the Paranasal Sinuses in an Immunologically Competent Host. Otolaryngology. 107(1). 115–119. 15 indexed citations

12.

Amorosi, Edward L., et al.. (1989). Neutropenic typhlitis simulating carcinoma of the cecum. Gastrointestinal Endoscopy. 35(5). 449–451. 4 indexed citations

13.

Lewis, Ronald T., Richard J. Duma, Roger Echols, et al.. (1988). Comparative study of cefotetan and cefoxitin in the treatment of intra-abdominal infections. American Journal of Obstetrics and Gynecology. 158(3). 728–735. 9 indexed citations

14.

Wilson, Samuel E., John A. Boswick, Richard J. Duma, et al.. (1988). Cephalosporin therapy in intraabdominal infections. The American Journal of Surgery. 155(5). 61–66. 28 indexed citations

15.

Grossi, Eugene A., Alfred T. Culliford, Karl H. Krieger, et al.. (1985). A Survey of 77 Major Infectious Complications of Median Sternotomy: A Review of 7,949 Consecutive Operative Procedures. The Annals of Thoracic Surgery. 40(3). 214–223. 264 indexed citations

16.

Rosenberg, A., Robert Press, David G. Silverman, et al.. (1983). Ceftazidime therapy of infections caused by Enterobacteriaceae and Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 12(suppl A). 213–217. 17 indexed citations

17.

Margolis, Richard U., Robert Press, & N. Altszuler. (1972). Increased fructose production by the brain in alloxan diabetes. Brain Research. 38(2). 371–375. 3 indexed citations

18.

Press, Robert, et al.. (1971). Isolation of Transducing Particles of ϕ80 Bacteriophage That Carry Different Regions of the Escherichia coli Genome. Proceedings of the National Academy of Sciences. 68(4). 795–798. 58 indexed citations

19.

Margolis, R. U., Robert Press, N. Altszuler, & Moira Stewart. (1971). Inositol production by the brain in normal and alloxan-diabetic dogs. Brain Research. 28(3). 535–539. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact